Article Information
History
- August 28, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Peter J Godolphin, PhD1,*,
- David J Fisher, MSc1,
- Lindsay R Berry, PhD2,
- Lennie PG Derde, MD, PhD3,
- Janet V Diaz, MD4,
- Anthony C Gordon, MBBS, MD5,
- Elizabeth Lorenzi, PhD2,
- John C Marshall, MD6,
- Srinivas Murthy, MD, CM, MHSc7,
- Manu Shankar-Hari, PhD, MSc8,9,
- Jonathan AC Sterne, PhD10,11,12,
- Jayne F Tierney, PhD1 and
- Claire L Vale, PhD1
- 1MRC Clinical Trials Unit at University College London, Institute of Clinical Trials and Methodology, London, UK
- 2Berry Consultants, Austin, TX, United States
- 3University Medical Center Utrecht, Department of Intensive Care Medicine, Utrecht, the Netherlands
- 4Clinical Unit, Health Emergencies Programme, World Health Organization, Geneva, Switzerland
- 5Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College London, London, UK
- 6Li Ka Shing Knowledge Institute, St Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada
- 7Department of Pediatrics, University of British Columbia, Vancouver, Canada
- 8Guy’s and St Thomas’ NHS Foundation Trust, St Thomas’ Hospital, London, UK
- 9School of Immunology & Microbial Sciences, Kings College London, London, UK
- 10Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
- 11NIHR Bristol Biomedical Research Centre, Bristol, UK
- 12Health Data Research UK South West, UK
- ↵*Corresponding Author:
Peter J Godolphin, 2nd Floor, 90 High Holborn, MRC Clinical Trials Unit at University College London, Institute of Clinical Trials and Methodology, London, WC1V 6LJ, UK. p.godolphin{at}ucl.ac.uk